Effect of Silymarin Against Methotrexate-induced Liver Injury in Rheumatic Diseases
Status:
RECRUITING
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
To study the effect of silymarin against methotrexate-induced liver injury in rheumatic diseases including rheumatoid arthritis, psoriatric arthritis and psoriasis